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Context: Research has shown the modulations of Follistatin (FST) and Myostatin (MST) following weight loss 33 
Objective: We evaluated the effects of gradual weight loss (GWL) and rapid weight loss (RWL) on serum MST, 34 
FST concentrations, and body composition in overweight and obese females.  35 
Materials and Methods: Thirty-six overweight and obese females successfully completed the study interventions: 36 
GWL (n = 18) or RWL (n= 18). Serum MST and FST concentrations, as well as anthropometric measurements, 37 
were collected at baseline and at the conclusion of each weight loss intervention.  38 
Results: MST significantly (p<0.05) concentration decreased in the GWL; while FST, body fat percentage and 39 
skeletal muscle mass significantly declined in both conditions. The loss in skeletal muscle mass was significantly 40 
greater in RWL relative to GWL. 41 
Discussion and Conclusion: GWL was more effective than RWL in preserving skeletal muscle mass in 42 
overweight and obese females. Moreover, GWL leads to declines in MST concentrations. 43 




















Excess caloric intake along with increased sedentarism have been reported as the most immediate contributors to 63 
the increasing occurrence of obesity in society, as well as the subsequent development of several non-64 
communicable diseases such as metabolic syndrome, type II diabetes mellitus, cardiovascular diseases, and 65 
specific types of cancers(Middelbeek & Breda, 2013). Given the importance of obesity-related health conditions, 66 
numerous strategies have been implemented aiming to reduce fat mass (FM). Dietary interventions leading to 67 
body mass (BM) loss have been suggested as the first stage to alleviate obesity and allied health risk factors 68 
(Jakicic et al., 2001). Correspondingly, diverse dietary interventions have been proposed for FM loss(Freire, 69 
2020). Most of the proposed strategies are based off the division of macronutrients (e.g. low-carbohydrate/high-70 
fat, high-carbohydrate/low-fat, or low-carbohydrate/high protein diet) (Floegel & Pischon, 2012; Yancy, Olsen, 71 
Guyton, Bakst, & Westman, 2004), manipulation of total energy balance to induce either gradual weight loss 72 
(GWL), or rapid weight loss (RWL) (Ashtary-Larky et al., 2018). Even though RWL approaches may be 73 
attractive to obese individuals, it has been theorized that GWL may yield finer alterations in body composition 74 
and anthropometric variables and be better maintained chronically (Ashtary-Larky et al., 2018). Indeed, prior 75 
work (Hill, 2008; Lutes et al., 2008; Sbrocco, Nedegaard, Stone, & Lewis, 1999) has advised a GWL method, 76 
contending that GWL may generate superior long-term FM levels compared with RWL, which is unlikely to be 77 
maintained. However, others (Astrup & Rössner, 2000; Carels, Cacciapaglia, Douglass, Rydin, & O'Brien, 2003; 78 
Elfhag & Rössner, 2005; Nackers, Ross, & Perri, 2010) have pointed out that larger calorie deficits and 79 
subsequent RWL are more likely to reinforce the BM-change process and produce superior long-term FM loss 80 
results. Accordingly, ambiguity continues concerning the optimal energy intake and rate of weight loss 81 
demanded most favorable for obesity management.   82 
     Some myokines such as myostatin (MST) and follistatin (FST) have been reported to be affected by both BM 83 
and FM alterations in humans (Flanagan et al., 2009; Hittel, Berggren, Shearer, Boyle, & Houmard, 2009; Milan 84 
et al., 2004). MST serves as a negative regulator of skeletal muscle mass (SMM) growth and differentiation, 85 
while FST acts as the regulator of MST through binding to the active form of MST and inhibiting the binding of 86 
MST to the activin IIB receptor(Amthor et al., 2004). Consequently, FST over-expression and MST inhibition is 87 
associated with increased SMM (Wagner, Liu, Chang, & Allen, 2005; Wagner, McPherron, Winik, & Lee, 2002) 88 
and decreased FM (McPherron & Lee, 1997; Yang et al., 2001). On the contrary, increased MST concentration 89 
have been reported to increase FM (Allen, Hittel, & McPherron, 2011; Reisz-Porszasz et al., 2003). FST was 90 
found to be more expressed in lean compared with obese females, and weight loss resulted in increased FST in 91 
 
obese females (Flanagan et al., 2009). For instance, some studies have reported MST (Allen, Cleary, Lindsay, 92 
Loh, & Reed, 2010; Allen et al., 2008; Gonzalez-Cadavid et al., 1998; Milan et al., 2004; Park, Berggren, 93 
Hulver, Houmard, & Hoffman, 2006) and FST (Allen et al., 2008; Flanagan et al., 2009) concentration to be 94 
changed following weight loss. Nevertheless, most studies investigated the intracellular expression (Allen et al., 95 
2010; Allen et al., 2008; Gonzalez-Cadavid et al., 1998; Milan et al., 2004; Park et al., 2006) or protein(Allen et 96 
al., 2010) in animals (Allen et al., 2010; Allen et al., 2008),  and only two studies conducted on obese 97 
humans(Milan et al., 2004; Park et al., 2006). Although these previously mentioned studies were conducted on 98 
weight loss, fewer studies have examined the alterations of FST and MST concentrations following the rate of 99 
weight loss. Only Motevalli et al. (2015) reported a significant increase in MST and a decrease in FST 100 
concentration following RWL compared to GWL in competitive wrestlers(Motevalli et al., 2015).    101 
Combined, these studies suggest a relationship between BM and/or FM reductions and the MST 102 
signaling pathway. However, little attention has focused on MST and FST following weight loss in sedentary 103 
females. Given the effects of MST and FST in regulating SMM and FM, we hypothesized that FST and MST 104 
could be affected by the rate of weight loss. Accordingly, as the primary purpose, this paper aimed to evaluate 105 
alterations in MST and FST concentrations following different models of FM loss (RWL vs GWL) in 106 
overweight and obese females. As a secondary aim, we assessed body composition changes after RWL and 107 
GWL. 108 
Materials and Methods  109 
Participants 110 
Thirty-six overweight and obese (body mass index, BMI >25 kg/m2) female participants who were referred to 111 
our nutrition clinic [(Ahvaz, Iran); (age: 35 ± 11 y, weight: 83.7 ± 13.6 kg, BMI: 33.1 ± 6.9  kg/m2)] successfully 112 
completed this study. The study protocol was approved by the Ethics Committee of Jundishapur University of 113 
Medical Sciences and conducted in accordance with the Declaration of Helsinki and was registered in Iranian 114 
Registry of Clinical Trials (IRCT2016010424699N2). Procedures were explained to participants and written 115 
informed consent was obtained before participation.  Inclusion criteria were as follows: not to contribute in any 116 
physical activity (PA) at least in the last year (self-reported), not to use alcohol or smoke, not to use herbal 117 
supplements and vitamins, and a lack of BM changes in the last 6 months (self-reported). Exclusion criteria were 118 
non-willingness to continue nutritional protocols, participation in other dietary weight loss procedures, 119 
pregnancy, or breastfeeding, use of effective drugs on metabolism, lipid and glycemic profile, eating disorder, 120 
diabetes, cardiovascular disease, kidney problems, thyroid, digestive, and respiratory diseases. In addition, 121 
 
participants consuming more than 300 mg of caffeine daily (described as caffeine users (Shirali et al., 2016)) 122 
were excluded from the study.  123 
Study design 124 
This double-blinded clinical trial was conducted on overweight and obese female participants. All participants 125 
were initially screened for enrolment by phone and social media (Instagram or Telegram) and scheduled for a 126 
preliminary visit at nutrition clinic (preliminary visit). The preliminary session included measures of height, 127 
weight, waist circumference and questionnaires that confirm their eligibility for the study. Subsequently, 128 
Participants were randomly assigned into a GWL (n = 18; 34.4 ± 7.4 y, 83.6 ± 13.5 kg, 44 ± 6.4 body fat percentage 129 
[BFP]) or RWL (n= 18; 33.1 ± 11.7 y; 83.7 ± 14.1 kg; 40.8 ± 9.6 BFP) condition. Participants were asked not to 130 
change their PA levels throughout the study. 131 
Diet protocol 132 
The methods and design of were previously reported in detail elsewhere (Ashtary-Larky et al., 2017). Briefly, 133 
RWL and GWL, based on the lost weight (at least 5 %), were defined over a period of 5 weeks and 15 weeks, 134 
respectively. Dietary restrictions were calculated from individual daily energy expenditure requirements. Total 135 
energy expenditure was estimated from the Dietary Reference Intake (DRI) for non-obese adult women(Table, 136 
2005). The DRI prediction formula requires an estimate of the level of PA, age, weight, and height. To achieve 137 
and maintain the dietary energy restriction, the food exchange system from the Academy of Nutrition and Dietetics 138 
and American Diabetes Association  was used(Wheeler, Daly, & Evert, 2014). The prescribed calorie-restricted 139 
diet contained 15% protein, 30% to 35% fat, and 50% to 55% carbohydrate, on average, in order to provide weight 140 
loss. In general, the meal plans included 3 main meals (breakfast, lunch, and dinner) and three snacks (mid-141 
morning, mid-afternoon, and bedtime), and low saturation and trans fats, cholesterol, salt (sodium), and added 142 
sugars. All diets were designed according to Dietary Guidelines for Americans, 2010 (Motevalli et al., 2015). Low-143 
calorie diets produced an energy deficit of 500 to 750 for the 15-week duration GWL, and 1000 to 1500 kcal/d for 144 
the 5-week duration for the RWL.  145 
Anthropometric measurements 146 
Prior to arriving to the laboratory, participants fasted for 12 hours (overnight, with an aim of 8 hours sleep), 147 
refrained from consuming alcohol for 48 hours caffeinated beverages, and other diuretics before assessments. 148 
The stature was measured with a stadiometer (Race Industrialization, China) to the nearest 0.1 cm. BM, BMI, 149 
BFP, waist-hip ratio (WHR), and SMM were evaluated by a multi-frequency bioelectrical impedance device 150 
 
(Inbody 230, Biospace, Korea) (Bagheri, Rashidlamir, Motevalli, et al., 2019). The test-retest reliability of the 151 
bioelectrical impedance method was high (R = 0.95 to 0.98).  152 
Blood sampling and laboratory analysis 153 
Fasting blood samples (5 mL) were taken from the cubital vein using standard procedures following 12-hour 154 
overnight fasting (Bagheri, Rashidlamir, Ashtary‐Larky, et al., 2019). The initial collection occurred 48 hours 155 
before initiation of dieting. Blood samples were clotted and stored for 20 minutes at room temperature before 156 
being centrifuged at 3000 revolutions per minute for 20 minutes. Spun serum was removed from the centrifuge 157 
and frozen at -80°C. Serum MST (human MST, Zellbio Gmbh, Germany) and FST (human FST, Zellbio 158 
Gmbh, Germany) concentration were measured in duplicate using enzyme-linked immunosorbent assay 159 
(ELISA) with a microplate reader (GDV, Germany) at a wavelength of 450 nm. The intra-assay and inter-assay 160 
coefficient of variation were less than 10% and 12% for MST and FST, respectively. 161 
Nutrient intake and dietary analysis 162 
Participants in RWL submitted 3-day (2 weekdays and 1 weekend) food records at baseline and after week 3 and 163 
5, while participants in GWL submitted their food records at baseline and after week 3, 6, 9, 12, and 15.  Each 164 
item of food was individually entered into Diet Analysis Plus version 10 (Cengage, Boston, MA, USA) and total 165 
energy consumption, and the amount of energy derived from proteins, fats, and carbohydrates was assessed 166 
(Bagheri, Rashidlamir, Motevalli, et al., 2019).  167 
Statistical analysis 168 
An a priori sample size calculation was conducted using the G*Power analysis software (Faul, Erdfelder, Lang, 169 
& Buchner, 2007). Our rationale for sample size was based on our prior data (Bagheri et al., 2020) and estimated 170 
that 15 participants per condition ( 30 total participants) would provide 80% power (two-sided α = 0.05) to detect 171 
significant change in FST and MST concentrations. Shapiro-Wilk test was performed to assess the normality of 172 
data.  Student’s t test was performed for condition comparisons at baseline. A 2 × 2 RM ANOVAs [time (pre-173 
intervention vs. post-intervention) × condition (GWL vs. RWL)] with Bonferroni adjustments was used to 174 
determine treatment differences. When appropriate, a one-way ANOVA across change scores was used to detect 175 
between-condition differences. Following extra sum-of squares F test, Pearson’s correlation was performed 176 
between body composition and endocrine markers with data treated as one condition or separated by condition 177 
(GWL vs RWL) as suitable. Statistical significance was set at p < 0.05. Cohen’s d effect size (ES) was calculated 178 
as post effect mean minus pre effect mean/pooled pre effect standard deviation means(Cohen, 1992). An ES of 179 
 
0.00-0.19 was considered trivial, 0.20-0.49 = small, 0.50-0.79 = moderate, and ≥ 0.80 = large. All analyses were 180 
performed using SPSS (version 25.0, IBM; Chicago, IL). 181 
Results 182 
Of sixty-five participants that assessed for eligibility, forty-one participants underwent evaluation. Twenty 183 
participants were assigned to RWL and 21 were assigned to GWL. Of these, 36 participants completed the study 184 
(18 participants per condition). During the study, two participants in RWL (inability for maintaining diet) and 185 
three in GWL (exercising, pregnancy, or medication) were excluded. No adverse events in the two study conditions 186 
were reported. Baseline characteristics of RWL and GWL conditions are presented in Table 1. No significant 187 
differences were observed at baseline between two conditions for any variable (Table 1). 188 
Energy and macronutrients consumption  189 
Energy and macronutrients of RWL and GWL are presented in Table 2. A significant main effect of time was 190 
observed for kilocalories, protein, fat, and carbohydrate consumption in both conditions (P<0.05). Participants in 191 
RWL condition consumed significantly less kilocalories, protein, fat, and carbohydrates during week 3 and 5 192 
compared to baseline. Participants in GWL condition consumed significantly less kilocalories, protein, fat, and 193 
carbohydrates during week 3, 6, 9, 12, and 15, compared to baseline (P<0.05). In addition, participants in GWL 194 
condition consumed significantly less kilocalories comparted to week 3, 6, and 9 (P<0.05). In addition, participants 195 
in GWL condition during week 12 consumed significantly less protein compared to week 3. Moreover, participants 196 
in GWL condition during week 12 consumed less carbohydrate compared to week 6 and 9 (P<0.05).  197 
Rate of weight loss alters body composition 198 
A significant condition × time interaction was detected for BFP [(p = 0.002), (Figure 1B)] and SMM [(p < 0.001), 199 
(Figure 1C)]. BFP [GWL = -2.8 % (95% CI= -3.5 to -2.1), (d= 1.9) and RWL = -1.2 % (95% CI, -1.9 to -0.5), (d= 200 
0.9)] and SMM [GWL = -0.4 kg (95% CI= -0.7 to -0.1), (d= 0.7) and RWL = -1.4 kg (95% CI, -1.7 to -1), (d= 2)] 201 
significantly decreased in both conditions over time. No condition × time interaction was noted for BM (p = 0.637), 202 
BMI (p= 0.403) or WHR [p= (0.202), (Figure 1A)]. Each variable was noted to be significantly decreased with 203 
time BM (p < 0.001, η2 = 0.961), BMI, (p < 0.001, η2 = 0.957), BFP (p < 0.001, η2 = 0.679), WHR (p < 0.001, 204 
η2 = 0.573), and SMM (p < 0.001, η2 = 0.680); (Table 1). When SMM was examined as change in (post-pre, 205 
ΔSMM), significantly greater loss in SMM was noted in RWL relative to GWL (p < 0.001, Figure 1D). 206 
GWL condition alters MST and FST while RWL only alters FST concentration 207 
A significant condition × time interaction was detected for MST [(p = 0.011), (Figure 1E)], FST [(p = 0.036), 208 
(Figure 1F)], and FST/MST ratio [(p = 0.006), (Figure 1G)]. MST only decreased in GWL [GWL = -44.4 ng/l 209 
 
(95% CI= -67.4 to -21.5), (d= 0.9)] while FST [GWL = -3 ng/ml (95% CI= -4.6 to -1.5), (d= 0.3) and RWL= -5 210 
ng/ml (95% CI, -6.2 to -3.9), (d= 2.1)] significantly decreased in both conditions. In addition, FST/MST ratio 211 
[RWL= -0.01 (95% CI, -0.02 to -0.006), (d= 0.9)] significantly diminished in RWL.   212 
Change in FST associates with change in BFP independent of weight loss model 213 
Following sum-of-square F-test, weight loss condition was either ignored (Figure 2C and 2D), or considered 214 
(Figure 2B) when examining changes in endocrine markers as a function of change in body composition. The 215 
alteration in FST (ΔFST) was differentiated between GWL and RWL (p = 0.013), and the change in BFP (ΔBFP) 216 
in both conditions was associated with ΔFST (GWL r2 = 0.531, p = 0.025; RWL r2 = 0.342, p = 0.011; Figure 2B). 217 
No other condition was differentiated by sum-of-squares F test, nor considered to be associated by Pearson’s 218 
correlation when considered as one condition (Figure 2A) r2 = 0.023, p = 0.382; Figure 2C), r2 = 0.098, p = 0.063; 219 
Figure 2D), r2 = 0.020, p = 0.413).   220 
Discussion 221 
The major findings were as follows: GWL resulted in a significant decrease in MST concentration, an effect not 222 
seen in the RWL group. In addition, both GWL and RWL resulted in a significant decrease in FST concentration. 223 
The FST/MST ratio significantly diminished in RWL. In regards to body composition, BFP significantly decreased 224 
in both conditions. Moreover, significantly greater loss in SMM was noted in RWL relative to GWL. Collectively, 225 
our results suggest a more catabolic environment in the RWL than the GWL condition.   226 
      MST is a member of transforming growth factor-beta (TGF-β) family member which inhibits muscle 227 
differentiation and growth(Allen et al., 2011). Mice in which MST processing or signaling is disrupted exhibited 228 
muscle mass gains (Matsakas et al., 2009; Yang et al., 2001), while MST over-expression resulted in a significant 229 
decrements of muscle mass(Reisz-Porszasz et al., 2003). These results confirm MST’s critical role in inhibiting 230 
muscle mass gains.  Follistatin is a member of the TGF-β superfamily (Görgens et al., 2013), which is ubiquitously 231 
expressed in all tissues of the human body, including skeletal muscle, and has both paracrine and autocrine 232 
influences. FST has shown to bind MST and inhibit its activity(Nakatani, Kokubo, Ohsawa, Sunada, & Tsuchida, 233 
2011), but also can bind and inhibit other TGF-β family members (Tsuchida et al., 2000), suggesting a more 234 
diverse physiological role. Obesity is associated with increased MST expression in both adipose and skeletal 235 
muscle tissues(Allen et al., 2011), and MST mRNA levels decreased during weight loss following daily injection 236 
of recombinant leptin in mice (Allen et al., 2008). Similarly, circulating FST concentration is also elevated in 237 
obese individuals relative to normal weight controls (Maïmoun et al., 2020), concentration of which is 238 
 
subsequently reduced following bariatric surgery-induced weight loss (Wiewiora et al., 2020). These results 239 
highlight a role of weight loss to reduce MST and FST concentrations. 240 
To date, only one study has been conducted comparing GWL and RWL on serum MST and FST concentrations. 241 
Motevalli et al. (2015) examined 8 weeks of weight loss in male competitive wrestlers, serum MST and FST 242 
concentrations remained unchanged in the GWL condition while a significant increase in serum MST and a 243 
significant decrease in FST concentration was observed in the RWL condition. In their study, serum MST/FST 244 
was significantly increased in the RWL condition (Motevalli et al., 2015), suggesting a more catabolic environment 245 
was present in the RWL compared to RWL condition, similar to the findings of the results we present herein.  246 
At the end of our study, GWL experienced 711 kcal/d and 13.6 g/d of protein reduction in daily energy intake 247 
while RWL experienced a quite severe 1339 kcal/d and 44.2 g/d of protein reduction. Moreover, FST/MST was 248 
decreased following RWL, indicating a drop in positive muscle growth leading to their deficiency in the 249 
homeostatic balance of the muscle. Considering the losses in SMM observed our RWL participants, ultimately 250 
these changes may have led to a greater catabolic condition in RWL compared to GWL. The main mechanism of 251 
this catabolic condition could be due the activation of AMP-activated protein kinase (AMPK), which is an 252 
intracellular energy sensor and the activation of AMPK occurs when the ratio of ATP/ADP decreases in result of 253 
caloric restriction. The activation of AMPK can directly activate Tuberous Sclerosis 2 (TSC2) signaling, which is 254 
an antagonist of mTORC1 activation(Laplante & Sabatini, 2009), involved in the regulation of MST 255 
signaling(Elliott, Renshaw, Getting, & Mackenzie, 2012). It could be speculated that these mechanisms are 256 
responsible, at least in part, for inducing a catabolic intracellular condition witnessed herein; however, more 257 
invasive measures such as muscle biopsies would be required to confirm this mechanism.   258 
          Participants in GWL gradually reduced calories at a rate of 500-750 kcal/d for 15 weeks, while participants 259 
in RWL reduced calories at a rate of 1000-1500 kcal/d for 5 weeks. Both conditions significantly decreased BM, 260 
BFP, WHR, and SMM. It was not surprising, however, that SMM was decreased to a greater extent in RWL 261 
relative to GWL due to the respective reduction of daily protein intake of 44.2 g/d and 13.6 g/d. In a systematic 262 
review and meta-analysis study, we have shown the beneficial effects of GWL compared to RWL on BFP in 263 
overweight individuals, which is in line with the outcomes of the current study. However, our review also showed 264 
that fat-free mass was not different following both rates of weight loss (Ashtary Larky, Bagheri, Abbasnezhad, & 265 
M Tinsley, 2020). Additionally, previous studies showed that RWL diets are suboptimal for lean body mass 266 
preservation (Ashtary-Larky et al., 2017; Peos, Norton, Helms, Galpin, & Fournier, 2019; Vink, Roumans, 267 
Arkenbosch, Mariman, & van Baak, 2016). It has been shown that lean body mass contributes approximately 268 
 
ranged between 20-30% to total weight loss in individuals with overweight or obesity(Tinsley & Willoughby, 269 
2016). Our BFP and SMM results agree with the study of Motevalli et al. (2015) who observed a significant BFP 270 
reduction and lean body mass in both RWL and GWL conditions. In our study, GWL experienced a decrease in 271 
BFP by 3.2 % more than RWL, likely due to the longer caloric restriction. Indeed, our results revealed an 272 
interesting correlation between the changes in BFP and those of FST concentration in both conditions, with a 273 
higher r2 value (= 0.531) with GWL. These findings indicate that participants with smaller deteriorations in FST 274 
were the ones with higher decreases in BFP. Although it is not possible to infer causality from correlation, i.e., 275 
whether the smaller decrement of FST leads to a higher decrease in BFP or vice versa, the present findings are 276 
consistent with the model proposed by Brown et al. (2012) in which the declines in FST concentration may explain 277 
increases in fat mass in mice(Brown et al., 2011). The authors proposed that a deterioration in FST concentration 278 
could lead to an impaired glucose homeostasis and adipose tissue accumulation due to its important physiological 279 
roles in regulating these processes (Brown et al., 2011). 280 
      It is important to mention that our investigation possesses several limitations. First, we did not measure tissue 281 
level expression of MST and FST, which may give further insight into some of our results if collected at both 282 
muscle and sub-cutaneous adipose sites. However, it has been proposed that increases in circulating concentrations 283 
of cell-signaling molecules enhances the likelihood of receptor interaction and consequently improve the 284 
probability of a physiological effect within these tissues (Kraemer et al., 1990; Patel & Demontis, 2014). Second, 285 
we used bioelectrical impedance to measure body composition, which is more feasible in field-based settings but 286 
not as accurate as other options such as DEXA. However, previous studies have shown that it is a valid and reliable 287 
method (Jackson, Pollock, Graves, & Mahar, 1988; Ling et al., 2011). Since we evaluated MST and FST, as well 288 
as body composition markers following RWL and GWL in overweight female participants, our results may not be 289 
considered universal to all population types. Finally, we used self-reported dietary intake (via food record), which 290 
has been shown to be vulnerable to social desirability bias with under-reporting of energy intake and over-reporting 291 
of fruit and vegetable intake(Schoeller, 1995) . 292 
     This study was the first to evaluate the effects of GWL and RWL on serum FST and MST in overweight and 293 
obese females. Since both options resulted in matched weight loss, and RWL also resulted in reductions in MST 294 
and SMM, we would suggest the RWL condition induced a more catabolic environment for SMM and muscle 295 
protein. As a result, we conclude that GWL was more effective than RWL in preserving skeletal muscle mass in 296 
overweight and obese females. Future efforts should investigate if these differences in serum MST and FST and 297 
differences in SMM loss are maintained in the presence of caloric deficit but maintenance of dietary protein intake.  298 
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Figure 1: Alterations in Body Composition and endocrine markers with dietary condition. A) Hip / Waist ratio, 467 
B) BFP (%), C) SMM (kg) as a function of time (prior or post). D) ΔSMM (kg) by condition (GWL or RWL), E) 468 
Myostatin (ng.L-1), F) Follistatin (ng.mL-1), G) Follistatin/Myostatin ratio. Closed black circles indicate GWL and 469 
open grey circles indicate RWL. Horizontal red lines indicate condition means. Statistical comparisons and p 470 





Figure 2: Correlations between change in (Δ) Endocrine marker and Δ body composition. A) Δ Myostatin, B) Δ 476 
Follistatin as a function of ΔBFP, C) Δ Myostatin, D) Δ Follistatin as a function of ΔSMM (kg). Closed black 477 
circles indicate RWL and open grey circles indicate GWL. Solid red line indicates linear regression; shaded red 478 
zone indicates 95% confidence interval. Figures A), C), and D) treated as one condition (sum-of-squares F test A) 479 
p = 0.505, C) p = 0.177), and D) p = 0.063), Figure B) treated as two distinct conditions (p = 0.013). 480 
